Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Population Health | 3 | 2024 | 51 | 1.860 |
Why?
|
| Pharmacogenetics | 4 | 2022 | 260 | 1.140 |
Why?
|
| Genomics | 15 | 2024 | 2738 | 1.140 |
Why?
|
| Laboratories | 3 | 2024 | 145 | 0.880 |
Why?
|
| Computer Security | 1 | 2019 | 41 | 0.690 |
Why?
|
| Genetic Testing | 6 | 2021 | 1589 | 0.660 |
Why?
|
| Medical Records | 1 | 2019 | 415 | 0.630 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2024 | 5539 | 0.530 |
Why?
|
| Proteins | 7 | 2013 | 1963 | 0.510 |
Why?
|
| Genome, Human | 6 | 2021 | 1869 | 0.460 |
Why?
|
| Neptune | 1 | 2021 | 6 | 0.410 |
Why?
|
| Databases, Protein | 6 | 2015 | 100 | 0.330 |
Why?
|
| Protein Conformation | 5 | 2015 | 1258 | 0.320 |
Why?
|
| Cardiovascular Diseases | 4 | 2023 | 2195 | 0.310 |
Why?
|
| Electronic Health Records | 4 | 2023 | 929 | 0.290 |
Why?
|
| Evolution, Molecular | 6 | 2015 | 834 | 0.290 |
Why?
|
| Staphylococcus aureus | 1 | 2010 | 548 | 0.290 |
Why?
|
| Sequence Analysis, Protein | 3 | 2015 | 81 | 0.270 |
Why?
|
| Software | 5 | 2021 | 1321 | 0.270 |
Why?
|
| Computational Biology | 5 | 2020 | 1271 | 0.240 |
Why?
|
| Clinical Laboratory Services | 1 | 2024 | 42 | 0.230 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2024 | 2291 | 0.230 |
Why?
|
| Genetics, Medical | 2 | 2021 | 143 | 0.220 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2023 | 78 | 0.210 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2022 | 43 | 0.210 |
Why?
|
| Multifactorial Inheritance | 1 | 2021 | 148 | 0.190 |
Why?
|
| Neoplasms, Adipose Tissue | 1 | 2020 | 10 | 0.180 |
Why?
|
| Whole Genome Sequencing | 1 | 2022 | 338 | 0.180 |
Why?
|
| Organizational Case Studies | 1 | 2019 | 42 | 0.180 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2022 | 221 | 0.180 |
Why?
|
| Pancreatitis | 1 | 2022 | 267 | 0.180 |
Why?
|
| United States | 5 | 2024 | 15433 | 0.180 |
Why?
|
| Gastritis | 1 | 2022 | 373 | 0.160 |
Why?
|
| Medical Informatics | 1 | 2021 | 198 | 0.160 |
Why?
|
| Enzymes | 4 | 2013 | 64 | 0.160 |
Why?
|
| Hypoglycemia | 1 | 2020 | 213 | 0.160 |
Why?
|
| Molecular Sequence Annotation | 3 | 2013 | 201 | 0.160 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2019 | 203 | 0.160 |
Why?
|
| Abdominal Neoplasms | 1 | 2020 | 231 | 0.160 |
Why?
|
| Genetic Variation | 3 | 2021 | 2086 | 0.150 |
Why?
|
| Clinical Protocols | 1 | 2020 | 467 | 0.150 |
Why?
|
| Information Dissemination | 1 | 2018 | 272 | 0.130 |
Why?
|
| Exome | 1 | 2021 | 1239 | 0.130 |
Why?
|
| Cardiology | 1 | 2021 | 530 | 0.130 |
Why?
|
| Exons | 1 | 2019 | 1328 | 0.130 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 1011 | 0.120 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2020 | 986 | 0.120 |
Why?
|
| Humans | 22 | 2024 | 261506 | 0.120 |
Why?
|
| Seizures | 1 | 2020 | 989 | 0.120 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2017 | 435 | 0.120 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 1084 | 0.110 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 1516 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 4549 | 0.100 |
Why?
|
| Molecular Biology | 1 | 2013 | 176 | 0.100 |
Why?
|
| Phenotype | 2 | 2020 | 6295 | 0.100 |
Why?
|
| Biochemistry | 1 | 2010 | 24 | 0.100 |
Why?
|
| Cohort Studies | 4 | 2021 | 9244 | 0.100 |
Why?
|
| Likelihood Functions | 1 | 2010 | 233 | 0.090 |
Why?
|
| Algorithms | 5 | 2013 | 3890 | 0.090 |
Why?
|
| Proteome | 2 | 2013 | 561 | 0.090 |
Why?
|
| Cloning, Molecular | 1 | 2010 | 1213 | 0.080 |
Why?
|
| Cluster Analysis | 1 | 2010 | 1053 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 3 | 2020 | 2483 | 0.080 |
Why?
|
| Models, Genetic | 1 | 2010 | 1113 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 6009 | 0.070 |
Why?
|
| Genotype | 2 | 2024 | 4109 | 0.060 |
Why?
|
| Models, Statistical | 1 | 2010 | 1171 | 0.060 |
Why?
|
| Proteomics | 1 | 2010 | 1380 | 0.060 |
Why?
|
| Precision Medicine | 2 | 2021 | 1154 | 0.060 |
Why?
|
| Penetrance | 1 | 2023 | 126 | 0.050 |
Why?
|
| Proprotein Convertase 9 | 1 | 2023 | 69 | 0.050 |
Why?
|
| Health Level Seven | 1 | 2021 | 3 | 0.050 |
Why?
|
| Pharmacogenomic Testing | 1 | 2021 | 46 | 0.050 |
Why?
|
| Laboratory Proficiency Testing | 1 | 2020 | 19 | 0.050 |
Why?
|
| Loss of Function Mutation | 1 | 2020 | 132 | 0.040 |
Why?
|
| Reference Values | 1 | 2021 | 1099 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2024 | 1581 | 0.040 |
Why?
|
| Computer Communication Networks | 1 | 2018 | 44 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2022 | 672 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2020 | 414 | 0.040 |
Why?
|
| Polyps | 1 | 2018 | 74 | 0.040 |
Why?
|
| Cardiac Myosins | 1 | 2017 | 18 | 0.040 |
Why?
|
| Connectin | 1 | 2017 | 30 | 0.040 |
Why?
|
| Tropomyosin | 1 | 2017 | 38 | 0.040 |
Why?
|
| LIM Domain Proteins | 1 | 2017 | 104 | 0.040 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 442 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 2017 | 128 | 0.040 |
Why?
|
| Acute Disease | 1 | 2022 | 2422 | 0.040 |
Why?
|
| Germ-Line Mutation | 1 | 2022 | 1046 | 0.040 |
Why?
|
| Hyperlipidemias | 1 | 2018 | 235 | 0.040 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2017 | 136 | 0.040 |
Why?
|
| Syndrome | 1 | 2020 | 1351 | 0.040 |
Why?
|
| Pedigree | 1 | 2020 | 1890 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2023 | 12873 | 0.030 |
Why?
|
| Base Sequence | 1 | 2022 | 4917 | 0.030 |
Why?
|
| Prevalence | 1 | 2023 | 3260 | 0.030 |
Why?
|
| Colon | 1 | 2018 | 670 | 0.030 |
Why?
|
| Neoplasms | 1 | 2020 | 15193 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2017 | 549 | 0.030 |
Why?
|
| Epistasis, Genetic | 1 | 2013 | 119 | 0.030 |
Why?
|
| Exoribonucleases | 1 | 2013 | 42 | 0.030 |
Why?
|
| Male | 5 | 2022 | 123000 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2017 | 846 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 2013 | 275 | 0.030 |
Why?
|
| Species Specificity | 1 | 2013 | 777 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2012 | 549 | 0.020 |
Why?
|
| Myocardium | 1 | 2017 | 1313 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 1439 | 0.020 |
Why?
|
| Adult | 3 | 2023 | 77950 | 0.020 |
Why?
|
| Structural Homology, Protein | 1 | 2009 | 42 | 0.020 |
Why?
|
| Forecasting | 1 | 2013 | 694 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2017 | 2022 | 0.020 |
Why?
|
| Female | 4 | 2022 | 141928 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2021 | 6869 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2009 | 997 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2009 | 844 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 1029 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 4320 | 0.020 |
Why?
|
| Phylogeny | 1 | 2009 | 826 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 5687 | 0.020 |
Why?
|
| Risk Factors | 1 | 2023 | 17523 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2009 | 1732 | 0.020 |
Why?
|
| Internet | 1 | 2009 | 706 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2020 | 16273 | 0.010 |
Why?
|
| Middle Aged | 2 | 2018 | 86204 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 21445 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 31252 | 0.010 |
Why?
|
| Animals | 2 | 2013 | 59536 | 0.010 |
Why?
|
| Child | 1 | 2017 | 29154 | 0.010 |
Why?
|
| Mutation | 1 | 2013 | 15179 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 70117 | 0.010 |
Why?
|